The teaching hospital Sisters of Charity in Zagreb, Croatia, is one of the oldest hospitals in southern Europe.

There are 863 beds in Clinical Hospital Center "Sestre Milosrdnice".

During the past decade, Clinical Hospital Center "Sestre Milosrdnice" conducted 40 clinical trials. In the 10-year time frame, 40 clinical trials started and 25 clinical trials were completed, i.e. on average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 12 clinical trials were completed. i.e. 92.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Hospital Center "Sestre Milosrdnice"" #1 sponsor was "University Hospital "Sestre Milosrdnice"" with 9 trials, followed by "Celgene" with 7 trials sponsored, "Hoffmann-La Roche" with 7 trials sponsored, "Pfizer" with 4 trials sponsored and "Genzyme, a Sanofi Company" with 4 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Hospital Center "Sestre Milosrdnice"" #1 collaborator was "Bayer" with 3 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Parexel" with 2 trials as a collaborator, "Shire Human Genetic Therapies, Inc." with 2 trials as a collaborator and "Caris Life Sciences" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Hospital Center "Sestre Milosrdnice"" are "Crohn Disease" (5 trials), "Breast Cancer" (3 trials), "Carcinoma, Non-Small-Cell Lung" (3 trials), "Chemotherapy-Induced Nausea and Vomiting" (3 trials) and "Multiple Sclerosis, Relapsing-Remitting" (3 trials). Many other conditions were trialed in "Clinical Hospital Center "Sestre Milosrdnice"" in a lesser frequency.

Most popular intervention types in "Clinical Hospital Center "Sestre Milosrdnice"" are "Drug" (45 trials), "Biological" (10 trials), "Other" (8 trials), "Procedure" (4 trials) and "Diagnostic Test" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Ozanimod" (5 trials), "Interferon beta-1a" (4 trials), "Avelumab" (3 trials) and "Carboplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Hospital Center "Sestre Milosrdnice"" are 57 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Clinical Hospital Center "Sestre Milosrdnice"". undefined are not yet recruiting, 6 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 34 completed trials in Clinical Hospital Center "Sestre Milosrdnice", undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Hospital Center "Sestre Milosrdnice", 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 41 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 5 trials that are defined as “Not Applicable".